Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(5):387–392. doi: 10.1155/S0962935194000542

The Effect of IFN-γ, Alum and Complete Freund Adjuvant on TNP-KLH Induced Ig.G1, IgE and IgG2a Responses in Mice

R van Ommen 1,✉, A E C M Vredendaal 1, M de Gooyer 1, A van Oudenaren 1, H F J Savelkoul 1
PMCID: PMC2365572  PMID: 18475585

Abstract

Adjuvants are considered to play an important role in directing the isotype and amount of antibodies produced upon immunization by conducting the development of either Th-1 or Th-2 cells upon T-cell stimulation. This is based on the different cytokine production patterns that were observed after in vitro resttmulation of T cells isolated from mice immunized with antigen either adsorbed on alum or emulsified in complete Freund adjuvant (CFA). However, other studies suggest that primarily the type of antigen determines which isotypes are produced and to what extent. In these studies, however, IgE was not determined. Therefore, this study examined whether alum and CFA influenced the amount and/or ratio of IgG1, IgE and IgG2a produced after TNP-KLH immunization. Similar levels of IgG1, IgE and IgG2a antibodies were found upon immunization with TNP-KLH either adsorbed on alum or emulsified in CFA. Moreover, administration of IFN-γ in combination with TNP-KLH adsorbed on alum did not increase the amount of IgG2a produced. IFN-γ treatment resulted in an increased IL-6 and decreased IFN-γ production by spleen cells upon Con A stimulation, whereas it did not change the IL-4 production in similar conditions. The presented results suggest that upon immunization with TNP-KLH high IL-4 levels are produced, resulting in an antibody response that is dominated by IgG1, independent of the adjuvant employed. The IL-4 inducing property of TNP-KLH is substantiated by the finding that repeated immunization of mice with TNP-KI, without adjuvant, increases the serum total IgE level. The presented data suggest that the carrier part of TNP-KLH preferentially results in Th-2 cell activity after which the adjuvant merely enhances the antibody responses generated.

Full Text

The Full Text of this article is available as a PDF (618.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989 Oct;84(4):1045–1049. doi: 10.1172/JCI114265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bibby D. C., Grimble R. F. Temperature and metabolic changes in rats after various doses of tumour necrosis factor alpha. J Physiol. 1989 Mar;410:367–380. doi: 10.1113/jphysiol.1989.sp017538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blatteis C. M., Xin L., Quan N. Neuromodulation of fever: apparent involvement of opioids. Brain Res Bull. 1991 Feb;26(2):219–223. doi: 10.1016/0361-9230(91)90230-h. [DOI] [PubMed] [Google Scholar]
  5. Brakenhoff J. P., de Groot E. R., Evers R. F., Pannekoek H., Aarden L. A. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol. 1987 Dec 15;139(12):4116–4121. [PubMed] [Google Scholar]
  6. Coceani F., Lees J., Dinarello C. A. Occurrence of interleukin-1 in cerebrospinal fluid of the conscious cat. Brain Res. 1988 Apr 19;446(2):245–250. doi: 10.1016/0006-8993(88)90883-9. [DOI] [PubMed] [Google Scholar]
  7. Cunha F. Q., Ferreira S. H. The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur J Pharmacol. 1986 Sep 23;129(1-2):65–76. doi: 10.1016/0014-2999(86)90337-7. [DOI] [PubMed] [Google Scholar]
  8. Cunha F. Q., Souza G. E., Ferreira S. H. Macrophages stimulated with lipopolysaccharide release a selective neutrophil chemotactic factor: an in vivo demonstration. Braz J Med Biol Res. 1986;19(6):775–777. [PubMed] [Google Scholar]
  9. DeForge L. E., Kenney J. S., Jones M. L., Warren J. S., Remick D. G. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol. 1992 Apr 1;148(7):2133–2141. [PubMed] [Google Scholar]
  10. Dinarello C. A., Cannon J. G., Mier J. W., Bernheim H. A., LoPreste G., Lynn D. L., Love R. N., Webb A. C., Auron P. E., Reuben R. C. Multiple biological activities of human recombinant interleukin 1. J Clin Invest. 1986 Jun;77(6):1734–1739. doi: 10.1172/JCI112495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Faccioli L. H., Souza G. E., Cunha F. Q., Poole S., Ferreira S. H. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions. 1990 Jun;30(3-4):344–349. doi: 10.1007/BF01966298. [DOI] [PubMed] [Google Scholar]
  12. Gordon C. J. Thermal biology of the laboratory rat. Physiol Behav. 1990 May;47(5):963–991. doi: 10.1016/0031-9384(90)90025-y. [DOI] [PubMed] [Google Scholar]
  13. HANKS J. H., WALLACE J. H. Determination of cell viability. Proc Soc Exp Biol Med. 1958 May;98(1):188–192. doi: 10.3181/00379727-98-23985. [DOI] [PubMed] [Google Scholar]
  14. Hart P. H., Whitty G. A., Piccoli D. S., Hamilton J. A. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology. 1989 Mar;66(3):376–383. [PMC free article] [PubMed] [Google Scholar]
  15. Holt I., Cooper R. G., Hopkins S. J. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest. 1991 Oct;21(5):479–484. doi: 10.1111/j.1365-2362.1991.tb01398.x. [DOI] [PubMed] [Google Scholar]
  16. Hopkins S. J., Humphreys M. Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods. 1989 Jun 21;120(2):271–276. doi: 10.1016/0022-1759(89)90252-4. [DOI] [PubMed] [Google Scholar]
  17. Kettelhut I. C., Goldberg A. L. Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue. J Clin Invest. 1988 May;81(5):1384–1389. doi: 10.1172/JCI113467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kluger M. J. Fever: role of pyrogens and cryogens. Physiol Rev. 1991 Jan;71(1):93–127. doi: 10.1152/physrev.1991.71.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Knudsen P. J., Dinarello C. A., Strom T. B. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol. 1986 Nov 15;137(10):3189–3194. [PubMed] [Google Scholar]
  20. Lansdorp P. M., Aarden L. A., Calafat J., Zeiljemaker W. P. A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol. 1986;132:105–113. doi: 10.1007/978-3-642-71562-4_14. [DOI] [PubMed] [Google Scholar]
  21. LeMay L. G., Otterness I. G., Vander A. J., Kluger M. J. In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine. 1990 May;2(3):199–204. doi: 10.1016/1043-4666(90)90016-m. [DOI] [PubMed] [Google Scholar]
  22. Long N. C., Kunkel S. L., Vander A. J., Kluger M. J. Antiserum against tumor necrosis factor enhances lipopolysaccharide fever in rats. Am J Physiol. 1990 Feb;258(2 Pt 2):R332–R337. doi: 10.1152/ajpregu.1990.258.2.R332. [DOI] [PubMed] [Google Scholar]
  23. Long N. C., Vander A. J., Kunkel S. L., Kluger M. J. Antiserum against tumor necrosis factor increases stress hyperthermia in rats. Am J Physiol. 1990 Mar;258(3 Pt 2):R591–R595. doi: 10.1152/ajpregu.1990.258.3.R591. [DOI] [PubMed] [Google Scholar]
  24. Mathison J. C., Wolfson E., Ulevitch R. J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest. 1988 Jun;81(6):1925–1937. doi: 10.1172/JCI113540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Michie H. R., Spriggs D. R., Manogue K. R., Sherman M. L., Revhaug A., O'Dwyer S. T., Arthur K., Dinarello C. A., Cerami A., Wolff S. M. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988 Aug;104(2):280–286. [PubMed] [Google Scholar]
  26. Miñano F. J., Sancibrian M., Vizcaino M., Paez X., Davatelis G., Fahey T., Sherry B., Cerami A., Myers R. D. Macrophage inflammatory protein-1: unique action on the hypothalamus to evoke fever. Brain Res Bull. 1990 Jun;24(6):849–852. doi: 10.1016/0361-9230(90)90150-x. [DOI] [PubMed] [Google Scholar]
  27. Moore D. M., Cheuk S. F., Morton J. D., Berlin R. D., Wood W. B., Jr Studies on the pathogenesis of fever. 18. Activation of leukocytes for pyrogen production. J Exp Med. 1970 Jan 1;131(1):179–188. doi: 10.1084/jem.131.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nagai M., Saigusa T., Shimada Y., Inagawa H., Oshima H., Iriki M. Antibody to tumor necrosis factor (TNF) reduces endotoxin fever. Experientia. 1988 Jul 15;44(7):606–607. doi: 10.1007/BF01953311. [DOI] [PubMed] [Google Scholar]
  29. Nathan C. F. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. doi: 10.1172/JCI112815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Remick D. G., Strieter R. M., Lynch J. P., 3rd, Nguyen D., Eskandari M., Kunkel S. L. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest. 1989 Jun;60(6):766–771. [PubMed] [Google Scholar]
  31. Roth J., Conn C. A., Kluger M. J., Zeisberger E. Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am J Physiol. 1993 Sep;265(3 Pt 2):R653–R658. doi: 10.1152/ajpregu.1993.265.3.R653. [DOI] [PubMed] [Google Scholar]
  32. Rothwell N. J. Central effects of TNF alpha on thermogenesis and fever in the rat. Biosci Rep. 1988 Aug;8(4):345–352. doi: 10.1007/BF01115225. [DOI] [PubMed] [Google Scholar]
  33. Rothwell N. J., Hardwick A. J., Lindley I. Central actions of interleukin-8 in the rat are independent of prostaglandins. Horm Metab Res. 1990 Nov;22(11):595–596. doi: 10.1055/s-2007-1004981. [DOI] [PubMed] [Google Scholar]
  34. Rothwell N. J. Mechanisms of the pyrogenic actions of cytokines. Eur Cytokine Netw. 1990 Oct-Nov;1(4):211–213. [PubMed] [Google Scholar]
  35. Smith B. K., Kluger M. J. Anti-TNF-alpha antibodies normalized body temperature and enhanced food intake in tumor-bearing rats. Am J Physiol. 1993 Sep;265(3 Pt 2):R615–R619. doi: 10.1152/ajpregu.1993.265.3.R615. [DOI] [PubMed] [Google Scholar]
  36. Souza G. E., Cunha F. Q., Mello R., Ferreira S. H. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions. 1988 Jul;24(3-4):377–380. doi: 10.1007/BF02028296. [DOI] [PubMed] [Google Scholar]
  37. Staruch M. J., Wood D. D. Reduction of serum Interleukin-1-like activity after treatment with dexamethasone. J Leukoc Biol. 1985 Feb;37(2):193–207. doi: 10.1002/jlb.37.2.193. [DOI] [PubMed] [Google Scholar]
  38. Suttles J., Giri J. G., Mizel S. B. IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. J Immunol. 1990 Jan 1;144(1):175–182. [PubMed] [Google Scholar]
  39. Tada H., Shiho O., Kuroshima K., Koyama M., Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods. 1986 Nov 6;93(2):157–165. doi: 10.1016/0022-1759(86)90183-3. [DOI] [PubMed] [Google Scholar]
  40. Tobler A., Meier R., Seitz M., Dewald B., Baggiolini M., Fey M. F. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood. 1992 Jan 1;79(1):45–51. [PubMed] [Google Scholar]
  41. Tocco-Bradley R., Moldawer L. L., Jones C. T., Gerson B., Blackburn G. L., Bistrian B. R. The biological activity in vivo of recombinant murine interleukin 1 in the rat. Proc Soc Exp Biol Med. 1986 Jun;182(2):263–271. doi: 10.3181/00379727-182-42338. [DOI] [PubMed] [Google Scholar]
  42. Van Zee K. J., DeForge L. E., Fischer E., Marano M. A., Kenney J. S., Remick D. G., Lowry S. F., Moldawer L. L. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol. 1991 May 15;146(10):3478–3482. [PubMed] [Google Scholar]
  43. Waage A., Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 1988 Feb;63(2):299–302. [PMC free article] [PubMed] [Google Scholar]
  44. Won S. J., Lin M. T. Endogenous pyrogen formation by human blood monocytes stimulated by polyriboinosinic acid:polyribocytidylic acid. Experientia. 1993 Feb 15;49(2):157–159. doi: 10.1007/BF01989421. [DOI] [PubMed] [Google Scholar]
  45. de Souza G. E., Ferreira S. H. Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions. 1985 Oct;17(1):97–103. doi: 10.1007/BF01966691. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES